Home/ Supplements/ Omega 3/ Kids Vita Plus Natural Orange Flavor

Kids Vita Plus Natural Orange Flavor

product on market Tablet or Pill Guardian Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 42% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The primary ingredients listed are basic macronutrients and minerals, which provide general energy and electrolyte balance. Research evidence for these components is strong, though they do not function as targeted therapeutic agents. The product maintains a high safety profile for general consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Kids Vita Plus Natural Orange Flavor
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
120
Servings
Botanical with Nutrients
Product Type
42%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
4 Calorie(s)
Total Fat
Total Carbohydrate
1 Gram(s) (1% DV)
Cholesterol
Sodium
5 mg
Dietary Fiber
Protein
Vitamin A
753 mcg (83% DV)
Vitamin C
87.4 mg (97% DV)
2.5 mcg (12% DV)
Within RDA (0.2× RDA) 608 studies (A:16, B:251)
6.75 mg (45% DV)
Within RDA (0.5× RDA) 179 studies (A:3, B:90)
375 mcg (30% DV)
Within RDA (0.3× RDA) 76 studies (A:0, B:33)
425 mcg (30% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:1)
5 mg (30% DV)
Within RDA (0.4× RDA) 196 studies (A:5, B:63)
2.5 mg (50% DV)
Within RDA (0.5× RDA) 2 studies — no high-quality reviews
0.5 mg (29% DV)
Within RDA (0.4× RDA) 114 studies (A:3, B:35)
11.25 mcg (37% DV)
Within RDA (0.4× RDA) 27 studies (A:0, B:11)
100 mcg (25% DV)
Within RDA (0.2× RDA) 226 studies (A:10, B:105)
1.5 mcg (60% DV)
Within RDA (0.6× RDA) 139 studies (A:1, B:44)
Calcium
1.75 mg (0.1% DV)
Iron
720 mcg (4% DV)
28.65 mcg (19% DV)
Within RDA (0.2× RDA) 245 studies (A:4, B:133)
1.5 mg (0.4% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
1 mg (9% DV)
Within RDA (0.1× RDA) 263 studies (A:6, B:134)
200 mcg (22% DV)
Within RDA (0.2× RDA) 37 studies (A:0, B:11)
80 mcg (3% DV)
Market median: 10.0mg (102 products) 9 studies — no high-quality reviews
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Cranberry, Powder
2 mg
Carrot, Powder
2 mg
Tomato, Powder
2 mg
Papaya extract
2 mg
Cherry, Powder
2 mg
California Grape, Powder
2 mg

Other Ingredients

Magnesium Stearate Silicon Dioxide Cottonseed Oil Strawberry flavor Dextrose Vanilla flavor Citric Acid Sorbitol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a nutritional supplement, take one to three tablets after meal, twice a day.

Warnings & Precautions

Keep out of reach of children.

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children, in case of accidental overdose, call a doctor or poison control center immediately.

Formulation Notes

Vitamins Minerals + Fruits and Veggies + Choline

Additional Information

Store in a cool dry place below 30 degrees C (86 degrees F) and avoid exposure to sunlight.

Made In USA With Globally Sourced Ingredients

Metadata

Product Details

UPC / SKU8 18174 02038 6
DSLD Entry Date2023-11-22
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID299124
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.